Skip to main content

Advances in heart failure take center stage at cardiovascular summit

 

UC Davis Health experts host conference to discuss cutting edge research and treatment of cardiovascular disease

Cardiovascular experts from UC Davis Health will present new research and clinical findings at the 2022 Heart Failure Summit on October 29, 2022.

The annual conference will focus on “Advances in Heart Failure” and will feature leading cardiology researchers, clinicians and surgeons, helping to shape clinical practices and research directions for a global audience.

This year’s scientific program provides an evidence-based approach to the evaluation and management of patients with heart failure. It focuses on key clinical updates and cases frequently encountered by health practitioners addressing specific gaps in the evaluation and management of patients with heart failure. These important updates and cases will serve as the backbone to a larger discussion. Topics will include about recent advances in medical therapy, challenges in clinical implementation and solutions, structural and surgical approaches and advanced cardiac care delivered following a heart-team approach.

The agenda for the summit includes:

  • Presentations on an evidence-based approach to the evaluation and management of patients with heart failure
  • Key clinical updates and cases addressing specific gaps in the evaluation and management of patients with heart failure
  • Recent advances in medical therapy, challenges in clinical implementation and solutions, structural and surgical approaches and advanced cardiac care delivered following a heart-team approach
  • A forum to exchange quality improvement and research findings
  • Invited patients who will share their perspective and discuss their care

Keynote speakers include Bob Kiaii, chief of Cardiothoracic Surgery; Gagan Singh, director of the Clinical Cardiovascular Research Unit; and Martin Cadeiras, medical director for the Advanced Heart Failure, Heart Transplantation and Mechanical Circulatory Support Device Program.